Magnoglia, TRB’s subsidiary in Monaco, was the main sponsor of the fully digital neuroscience conference “L’homme cérébral” that took place on March 13, 2021. This event was organised by the Fondation pour l’Étude du Système Nerveux (FESN) and focused on the theme “Memory”.
TRB is pleased to support the first 100% virtual WCO-IOF-ESCEO e-congress which will take place from August 20 to 22 and available online until November 20, 2020. We are waiting for your visit at our booth in the virtual exhibition area!
TRB is also proud to host a Satellite Symposium entitled “Hyaluronic acid efficacy in osteoarthritis: beyond standard clinical parameters” which will be available online until November 20, 2020. This Symposium, chaired by Prof. Jean-Yves Reginster, University of Liège, will focus on the use of additional endpoints in clinical trials evaluating the efficacy of intra-articular hyaluronic acid such as our Ostenil products in osteoarthritis.
In addition, two posters summarising post-hoc analyses of TRB-sponsored clinical trials will be presented during the congress. Dr. Maheu, APHP Hôpital St-Antoine, Paris, will present the results of a post-hoc analysis of OSTP-EUR-10-01, a study published last December in PLoS One. This analysis compares the various definitions of responders that can be used in osteoarthritis (PASS, OMERACT-OARSI, MCII) and aimed at identifying predictive factors of a better response following intra-articular injection of hyaluronic acid.
The second poster is focusing on diacerein, a symptomatic slow-acting drug for osteoarthritis (SYSADOA). Prof. Jean-Pierre Pelletier, University of Montréal Hospital Research Centre, will discuss a post-hoc analysis of the DISSCO trial (A multicentre study on the effect of DIacerein on Structure and Symptoms versus Celecoxib in Osteoarthritis) aimed at exploring the influence of patient age on the magnitude of response to treatment with diacerein. Data revealed no differences between the efficacy and safety profile of diacerein in knee osteoarthritis patients younger or older than 65 years of age.
We are looking forward to participating in the first virtual WCO-IOF-ESCEO congress and hope that you share our excitement!
TRB Chemedica International was one of the proud sponsors of the conference “L’homme cérébral” organized by the Fondation pour l’étude du Système Nerveux on the 30th of March 2019 in Monaco.
TRB Chemedica is pleased to invite you to the 5th International Symposium on Intra-Articular Treatment (ISIAT) in the beautiful city of Lisbon. The meeting is taking place from October 3 to 5 and we will be happy to meet you on our exhibition booth (#8-9).
TRB Chemedica will present at the the 125th International Congress of the French society of Ophthalmology
TRB Chemedica will be present at the 2019 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases WCO-IOF-ESCEO in Paris. Come and visit us on booth 17!
Visit us during the ESCRS in Marrakech. We look forward to welcoming you at our stand number M03 from February 21 to 23.
TRB Chemedica International will be present at the 31st congress of the French Rheumatology Society (Société Française de Rhumatologie) to be held at the Porte de Versailles Exhibition Center, Paris.
You are about to leave the TRB corporate website. This link will take you to a local TRB website. Medical practices and regulations can be different from one country to another.
As a result, the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.CONTINUE